Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | P4HB | P07237 | 2/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2453938 | 0.89 | PTGS1 (0.50) | CYP3A4CYP1A2MAPTCYP2D6CYP2C9 | |
| SCHEMBL1599758 | 0.79 | CYP3A4 (0.54) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL7898797 | 0.79 | CYP3A4 (0.54) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL18626121 | 0.79 | CYP3A4 (0.54) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL15184719 | 0.78 | CYP3A4 (0.50) | CYP3A4CYP1A2MAPTCYP2D6CYP2C9 | |
| SCHEMBL27675641 | 0.78 | HSD17B10 (0.46) | CYP3A4CYP1A2MAPTCYP2D6CYP2C9 | |
| SCHEMBL28062224 | 0.76 | CYP3A4 (0.51) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29664492 | 0.76 | KMT2A (0.54) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL1155200 | 0.76 | KMT2A (0.54) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL108101 | 0.74 | CYP3A4 (0.55) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140894-B1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA SPA (IT) | 2003-12-17 | — | — | EP | claimed |
| US-6342613-B1 | REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE | ENDURA S.P.A. (IT) | 2002-01-29 | — | — | US | claimed |
| EP-1140894-A1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA S.p.A. (IT) | 2001-10-10 | — | — | EP | claimed |
| WO-2000040575-A1 | PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS | ENDURA S.P.A. (IT) | 2000-07-13 | — | — | WO | claimed |
| US-6818428-B1 | FOR DIAGNOSING SPONDYLOEPIMETAPHYSEAL DYSPLASIA (SEMD)/DETECTION OF ALLELES IN HUMANS; GENE/PROTEIN THERAPY; FUSION PROTEINS; HIV TAT GENES/PROTEINS | CEDARS SINAI MEDICAL CENTER | 2004-11-16 | — | — | US | disclosed |
| CN-1138769-C | Process for synthesis of 5-(-hydroxyalkyl) benzo [1,3] dioxols | �����ɷ� | 2004-02-18 | — | — | CN | disclosed |
| EP-1140894-B1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA SPA (IT) | 2003-12-17 | — | — | EP | disclosed |
| EP-1140894-B1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA SPA (IT) | 2003-12-17 | — | — | EP | disclosed |
| US-20030195162-A1 | Genetic marker for spondyloepimetaphyseal dysplasia | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-16 | — | — | US | disclosed |
| US-6342613-B1 | REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE | ENDURA S.P.A. (IT) | 2002-01-29 | — | — | US | disclosed |
| US-6342613-B1 | REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE | ENDURA S.P.A. (IT) | 2002-01-29 | — | — | US | disclosed |
| US-6342613-B1 | REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE | ENDURA S.P.A. (IT) | 2002-01-29 | — | — | US | disclosed |
| US-6153429-A | TISSUES TRANSFECTED WITH A RECOMBINANT NUCLEIC ACID MOLECULE FROM A BOVINE PAPILLOMA VIRUS; FOR THE DETECTION OF ANTICARCINOGENIC COMPOUNDS | VERA GENICS LTD. (CA) | 2000-11-28 | — | — | US | disclosed |
| EP-1025206-A1 | CELL LINES USEFUL FOR (IN VITRO) ASSAY FOR IDENTIFICATION OF CARCINOGENS | Viratest Carcinogen Monitoring, Ltd. (CA) | 2000-08-09 | — | — | EP | disclosed |
| WO-2000040575-A1 | PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS | ENDURA S.P.A. (IT) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000040575-A1 | PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS | ENDURA S.P.A. (IT) | 2000-07-13 | — | — | WO | disclosed |
| WO-1999020743-A1 | CELL LINES USEFUL FOR IN VITRO ASSAY FOR IDENTIFICATION OF CARCINOGENS | VIRATEST CARCINOGEN MONITORING LTD. (US) | 1999-04-29 | — | — | WO | disclosed |
| EP-0891547-A1 | $i(IN VITRO) ASSAY FOR IDENTIFICATION OF CARCINOGENS | Viratest Carcinogen Monitoring, Ltd. (CA) | 1999-01-20 | — | — | EP | disclosed |
| US-5821049-A | In vitro assay for identification of carcinogens | VIRATEST CARCINOGEN MONITORING, LTD (CA) | 1998-10-13 | — | — | US | disclosed |
| WO-1997038308-A1 | IN VITRO ASSAY FOR IDENTIFICATION OF CARCINOGENS | VIRATEST CARCINOGEN MONITORING, LTD. (CA) | 1997-10-16 | — | — | WO | disclosed |